{"id":588,"date":"2021-02-22T14:03:08","date_gmt":"2021-02-22T14:03:08","guid":{"rendered":"http:\/\/events.marketsandmarkets.com\/blog\/?p=588"},"modified":"2021-02-22T14:03:08","modified_gmt":"2021-02-22T14:03:08","slug":"discussing-laboratory-miniaturization-hand-in-hand-with-microfabrication-and-nanotechnology-systems-integration-at-the-microscale-with-dr-vania-silverio-of-inesc-mn-portu","status":"publish","type":"post","link":"https:\/\/events.marketsandmarkets.com\/blognew\/discussing-laboratory-miniaturization-hand-in-hand-with-microfabrication-and-nanotechnology-systems-integration-at-the-microscale-with-dr-vania-silverio-of-inesc-mn-portu\/","title":{"rendered":"Discussing \u201cLaboratory miniaturization hand in hand with Microfabrication and Nanotechnology \u2013 systems integration at the microscale \u201cwith Dr. Vania Silverio of INESC-MN, Portugal."},"content":{"rendered":"\n

Dr. Vania Silverio is a\nMicrofluidics architect with strong background in microengineering. She\ncombines know-how in simulation, design and fabrication of micron-sized fluidic\npaths with the integration of sensing and actuation elements towards the\nminiaturization of laboratories.<\/p>\n\n\n\n

Dr. Silverio is the Leader\nof the Microfluidics group at INESC Microsystems and Nanotechnologies (INESC\nMN) providing modular microfluidic solutions. She is Invited Assistant\nProfessor at the Physics Department of Instituto Superior Tecnico (IST),\nULisboa where, among others, she is the responsible for the curricular course\non Microfluidics, unique in Portugal. She supervises PhD and MSc theses\nfocusing the development of Microfluidics to tackle a wide range of scientific\nproblems and applications from biomedical to aerospace, to pharmaceutical, etc.<\/p>\n\n\n\n

She has a Licenciatura in\nTechnological Chemistry (FCUL, ULisboa, 2003). As an Undergraduate Researcher\nshe focused on chemical fluid dynamics and thermodynamics (FCUL 1 year, INETI 1\nyear). She then targeted microfluidic flow and heat transfer research for 6\nyears as Research Assistant and during her PhD in Mechanical Engineering (2016,\nIST). She joined INESC MN in 2016 as a postdoc developing integrated\nmicrofluidic platforms for biomedical diagnostics.<\/p>\n\n\n\n

We\ninterviewed Dr. Vania Silverio about her thoughts on the growing\nsignificance of the Point of care Testing amidst a Global pandemic. The role of\nPOCT in dealing with Infectious diseases, her presentation at the Conference\nand her take on the conference program.<\/p>\n\n\n\n

Question:<\/strong> What is the significance of\nPoint of Care Testing in the time of global pandemic? <\/strong><\/strong><\/p>\n\n\n\n

Dr.\nSilverio:<\/strong><\/strong><\/p>\n\n\n\n

Point of Care testing enables fast and high quality testing even\nin low-resource, remote settings. In this sanitary crisis, POCT devices have\nproven to be essential elements for the testing strategy in several countries,\nespecially in the support of vulnerable patients, to sustain outbreak\ninvestigations, and protect frontline healthcare workers. And because POCT may\nprovide very fast results near the patient, it potentiates a prompt and\nadequate treatment.<\/p>\n\n\n\n

Question:<\/strong> How POCT is helping in diagnosis of Infectious Diseases and\nhow it is significant in current situation.<\/strong><\/p>\n\n\n\n

Dr.\nSilverio:<\/strong><\/strong><\/p>\n\n\n\n

Rapid,\ncost-effective and reliable sample-to-result is core to sustain accessible and\ntimely diagnosis and treatment of infectious diseases. POCT devices are\ncurrently being developed and\/or used to successfully meet the needs in the\ncurrent situation, even with technical, scientific and supply limitations.<\/strong><\/p>\n\n\n\n

Question:<\/strong> What are your views on the agenda\nand how helpful it is to the targeted audience.<\/strong><\/strong><\/p>\n\n\n\n

Dr.\nSilverio:<\/strong><\/strong><\/p>\n\n\n\n

Awareness of the scientific and technological state-of-the-art regarding\nPOCT development and usage is of utmost importance not only for the scientific\ncommunity, but for all the population. In that sense, the event promoted by\nMarketsandMarkets for the dissemination of world class strategies on Infectious\nDisease Diagnostics and Point-Of-Care Testing is very opportune.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Dr. Vania Silverio<\/strong> is one of the speakers at our 2nd Annual MarketsandMarkets\nInfectious Disease Diagnostics and Point-Of-Care Testing Virtual Conference<\/a> being held on March 11th<\/sup> -12th,\n2021<\/strong>. <\/p>\n\n\n\n

She will be presenting on the Day 2 of\nthe conference on the topic \u2013 \u2018Laboratory miniaturization hand in hand with\nMicrofabrication and Nanotechnology \u2013 systems integration at the microscale.\u2019<\/strong><\/p>\n\n\n\n

To Know more about her presentation, visit our\nwebsite \u2013  <\/a>https:\/\/bit.ly\/3gNnkOq<\/a><\/p>\n\n\n\n

If you wish to learn a great deal from her\nabout the POCT & Infectious diseases field then register\nonline<\/a> or email aradhna.robert@marketsandmarkets.com<\/a> to book\nyour slot at the conference.<\/p>\n","protected":false},"excerpt":{"rendered":"

Dr. Vania Silverio is a Microfluidics architect with strong background in microengineering. She combines know-how in simulation, design and fabrication of micron-sized fluidic paths with the integration of sensing and actuation elements towards the miniaturization of laboratories. Dr. Silverio is the Leader of the Microfluidics group at INESC Microsystems and Nanotechnologies (INESC MN) providing modular […]<\/p>\n","protected":false},"author":2,"featured_media":583,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_mi_skip_tracking":false},"categories":[3,2],"tags":[49,88,45,44,231,150,89,233],"_links":{"self":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts\/588"}],"collection":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/comments?post=588"}],"version-history":[{"count":1,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts\/588\/revisions"}],"predecessor-version":[{"id":589,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/posts\/588\/revisions\/589"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/media\/583"}],"wp:attachment":[{"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/media?parent=588"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/categories?post=588"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/events.marketsandmarkets.com\/blognew\/wp-json\/wp\/v2\/tags?post=588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}